Equities

Gabelli Healthcare & WellnessRx Trust

GRX:NYQ

Gabelli Healthcare & WellnessRx Trust

Actions
FinancialsClosed End Investments
  • Price (USD)10.45
  • Today's Change0.02 / 0.19%
  • Shares traded3.37k
  • 1 Year change+26.67%
  • Beta1.0412
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.000.05--
Total Receivables, Net0.776.630.48
Total Inventory------
Prepaid expenses0.010.000.00
Other current assets, total------
Total current assets0.786.680.48
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments238242350
Note receivable - long term------
Other long term assets------
Total assets239249351
LIABILITIES
Accounts payable0.223.52--
Accrued expenses0.340.240.28
Notes payable/short-term debt0.0000.07
Current portion long-term debt/capital leases------
Other current liabilities, total0.350.286.53
Total current liabilities0.914.046.88
Total long term debt534080
Total debt534080
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities544487
SHAREHOLDERS EQUITY
Common stock114125127
Additional paid-in capital------
Retained earnings (accumulated deficit)7080137
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity185205264
Total liabilities & shareholders' equity239249351
Total common shares outstanding161717
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.